Cardiac Rhythm Specialists — Reseda, California

Cardiac Rhythm Specialists is a clinical research site located in Reseda, California, United States 91335.

Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.

Cardiac Rhythm Specialists has participated in 6 clinical trials.

Therapeutic areas: Heart Failure, Externalized Conductors, Visual Lead Anomalies.

Sponsors: Abbott Medical Devices.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Reseda

Browse all research sites in California · View every site in Reseda

• GSK Investigational Site
• Neurosearch, Inc.
• SC3 Research-Reseda
• Reseda, California
• Acorda Site #5047
• Teva Investigational Site 29
• Del Carmen Medical Center
• Sage Investigational Site
• Neurosearch, Inc. - Reseda
• Pfizer Investigational Site
• SC3 Research Group Inc Reseda

Sponsor Feasibility Report

Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cardiac Rhythm Specialists?

Cardiac Rhythm Specialists has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cardiac Rhythm Specialists conducted?

Cardiac Rhythm Specialists has 6 clinical trials on record. Their work covers Heart Failure, Externalized Conductors, Visual Lead Anomalies.

Is Cardiac Rhythm Specialists accredited by Crixeo Clinical Trials?

Cardiac Rhythm Specialists has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cardiac Rhythm Specialists?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.